AKTIIA
At Aktiia, we're at the forefront of revolutionizing blood pressure management and comprehension globally. Harnessing cutting-edge AI-powered algorithms on top of over 300 million data points collected from more than 60,000 active users across the globe, we foster breakthroughs in hypertension comprehension and tailored patient care. Aktiia's CE-marked platform is currently available in seven European markets and approved as a medical device in 44 countries worldwide. And we continue to accelerate our efforts to achieve better health for the world.
AKTIIA
Industry:
Artificial Intelligence (AI) Health Care Health Diagnostics Medical Device Personal Health Wearables
Founded:
2018-05-07
Address:
Neuchâtel, Neuchatel, Switzerland
Country:
Switzerland
Website Url:
http://www.aktiia.com
Total Employee:
51+
Status:
Active
Total Funding:
59.68 M USD
Technology used in webpage:
Domain Not Resolving Amazon Mobile Non Scaleable Content HSTS IPv6 Person Schema Google Google Cloud Gravatar Profiles Cloudflare CDN
Similar Organizations
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Perceiv AI
AI-driven precision medicine, forecasting disease progression
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Vitara Biomedical
Vitara Biomedical develops a therapeutic platform to support premature infants.
XEED
XEED manufactures wearables to help understand and treat Parkinson's disease.
Current Advisors List
Board_member
2018-08-01
Board_member
Board_member
2021-01-01
Board_member
2018-01-01
Board_member
2023-01-01
Board_member
2018-01-01
Board_member
2018-01-01
Board_member
2017-01-01
Current Employees Featured
Josep Sola Co-founder & CTO @ Aktiia
Co-founder & CTO
2018-05-01
Mattia Bertschi Co-founder & CEO @ Aktiia
Co-founder & CEO
2018-07-01
Neil Puri Head of Quality and Regulatory Affairs @ Aktiia
Head of Quality and Regulatory Affairs
2022-10-01
Jay Shah Chief Medical Officer @ Aktiia
Chief Medical Officer
2021-11-01
Olivier Grossenbacher R&D Manager @ Aktiia
R&D Manager
2018-01-01
Jay Shah Chief Medical Officer @ Aktiia
Chief Medical Officer
2021-11-01
Founder
Investors List
Verve Ventures
Verve Ventures investment in Series A - Aktiia
redalpine
redalpine investment in Series A - Aktiia
Khosla Ventures
Khosla Ventures investment in Series A - Aktiia
415 Capital
415 Capital investment in Series A - Aktiia
Translink Capital
Translink Capital investment in Series A - Aktiia
Molten Ventures
Molten Ventures investment in Series A - Aktiia
Crowdcube
Crowdcube investment in Equity Crowdfunding - Aktiia
Molten Ventures
Molten Ventures investment in Series A - Aktiia
415 Capital
415 Capital investment in Series A - Aktiia
redalpine
redalpine investment in Series A - Aktiia
Newest Events participated
Official Site Inspections
http://www.aktiia.com Semrush global rank: 322.8 K Semrush visits lastest month: 118.85 K
- Host name: 139.212.105.34.bc.googleusercontent.com
- IP address: 34.105.212.139
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aktiia"
Aktiia - Crunchbase Company Profile & Funding
Aktiia’s mission has never been more critical, with over 1.4 billion people worldwide affected by high blood pressure, resulting in more than 18 million …See details»
About Us | Meet The Team | Aktiia
At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care. 2004. 2005 - 2017. 2011. May …See details»
Aktiia secures $42 million in Series B funding round …
2 days ago /CNW/ -- Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million ... Organization Profile. aktiia. Contact Cision. 866-245-2317 from 8 AM - 10 PM ETSee details»
Company Profile: Aktiia - pharmaphorum
Apr 27, 2025 Aktiia’s clinically validated, medical-grade technology supports a range of public healthcare initiatives, hypertension programmes, and blood pressure research initiatives …See details»
Aktiia SA - Swiss Biotech
At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care. ... Rue du Bassin 8a, 2000 …See details»
Aktiia - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Aktiia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Aktiia has 7 current employee profiles, including Co-founder & …See details»
Aktiia SA - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Aktiia Company Profile - Office Locations, Competitors, Revenue
Aktiia has 5 employees at their 1 location and $27.66 m in total funding,. See insights on Aktiia including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Resources - Aktiia Healthcare
Aktiia, the Swiss start-up revolutionizing Blood Pressure (BP) monitoring and management, announces it. Learn More. Podcast. Bringing a blood pressure device to global markets with …See details»
Aktiia SA - VentureRadar
Aktiia Unknown Privately Held Aktiia is dedicated to revolutionizing blood pressure monitoring through innovative, clinically accurate, and reliable solutions. Specializing in cuffless optical …See details»
About Us - Aktiia Healthcare
At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care. 2004. 2005 - 2017. 2011. May …See details»
aktiia SA - startupticker.ch
Jul 8, 2024 Aktiia was founded in Switzerland in May 2018 to create the best tool for diagnosis and treatment of hypertension. Aktiia’s founders, Mattia Bertschi (CEO) and Josep Solà …See details»
Aktiia - Funding, Financials, Valuation & Investors - Crunchbase
Aktiia is a healthcare company that provides blood pressure, digital therapeutics, and patient management services. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
Our Technology - Aktiia Healthcare
Aktiia enables precise, personalized medical care and research for BP. With over 20 years of research and hundreds of peer-reviewed publications, our commitment to scientific rigor is …See details»
Aktiia secures $42 million in Series B funding round and rebrands …
2 days ago Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by Earlybird Health and …See details»
Aktiia - Molten
Founded in Switzerland in May 2018, Aktiia’s team has some of the world's leading scientific and technical experts in optical blood pressure monitoring, including CTO, Dr. Josep Sola, a …See details»
Aktiia secures $42 million in Series B funding round and rebrands …
Jan 5, 2025 Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed. By integrating advanced AI algorithms with …See details»
aktiia SA - startup.ch
Aktiia SA: Aktiia was founded in Switzerland in May 2018 out of a passion to create the best tool for diagnosis and treatment of hypertension. Aktiia’s founders, Mattia Bertschi (CEO) and …See details»
Aktiia secures $42 million Series B funding and rebrands to Hilo
3 days ago In addition to announcing its rebranding to Hilo, Aktiia, a blood pressure intelligence platform, has completed an oversubscribed $42 million Series B funding round, bringing the …See details»
Evidence - Aktiia Healthcare
5 Aktiia Bracelet G1 has been CE-marked under the Medical Device Regulation (EU)2017/745 as a class IIa medical device. 6 ISO81060-2 Criterion 1 requires the mean difference of test …See details»